Literature DB >> 17032411

Differential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis C.

Qi He1, Camilla S Graham, Emanuele Durante Mangoni, Margaret James Koziel.   

Abstract

BACKGROUND/AIMS: The contribution of the host immune response to sustained virologic response is not clear in patients with chronic hepatitis C (CHC). The aim of this study was to explore the relationship of the toll-like receptor (TLR) expression with the outcome of antiviral therapy in hepatitis C viral infection.
METHODS: Peripheral blood mononuclear cells (PBMC) were obtained from 15 CHC patients before a 48-week treatment with pegylated interferon (PEG IFN) alpha-2a and ribavirin. A multiplex semi-quantitative reverse-trancriptase polymerase chain reaction (RT-PCR) was used to compare the relative abundance of TLR2-9 transcripts.
RESULTS: mRNA levels of TLR2, 3 and 6 were significantly higher in CHC subjects compared with normal controls (n=8). When patients were classified into non-responders (n=8) and sustained virological responders (n=7) according to the virological outcome of the treatment, there was a clear difference in baseline mRNA expression of TLRs and T-helper (Th) 1/2 cytokines. In addition, the mRNA expression of IFN-gamma and nuclear factor of activated T cells (NFAT), which is exclusively expressed in activated T cells, was inversely correlated with that of TLR4, 6 and 9 in non-responders.
CONCLUSIONS: TLRs mRNA levels are differentially expressed in baseline PBMC of chronic HCV-infected subjects with or without responsiveness to antiviral therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17032411     DOI: 10.1111/j.1478-3231.2006.01357.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  12 in total

1.  Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial.

Authors:  Lucivalda P M Oliveira; Rosangela P de Jesus; Ramona S S B Boulhosa; Carlos Mauricio C Mendes; Maria Cecilia Gnoatto; Denise C Lemaire; Maria Betania P Toralles; Lourianne N Cavalcante; Andre C Lyra; Luiz G C Lyra
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

2.  Cardiotrophin-1 promotes a high survival rate in rabbits with lethal fulminant hepatitis of viral origin.

Authors:  Maria Jesus Tuñon; Beatriz San Miguel; Irene Crespo; Jose Ignacio Riezu-Boj; Esther Larrea; Marcelino Alvarez; Iranzu González; Matilde Bustos; Javier González-Gallego; Jesus Prieto
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

3.  Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms.

Authors:  Ling Yang; Ekihiro Seki
Journal:  Front Physiol       Date:  2012-05-22       Impact factor: 4.566

4.  USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study.

Authors:  Sona Frankova; Milan Jirsa; Dusan Merta; Magdalena Neroldova; Petr Urbanek; Renata Senkerikova; Julius Spicak; Jan Sperl
Journal:  Ther Clin Risk Manag       Date:  2015-12-17       Impact factor: 2.423

Review 5.  Role of toll-like receptors in immune activation and tolerance in the liver.

Authors:  Nobuhiro Nakamoto; Takanori Kanai
Journal:  Front Immunol       Date:  2014-05-16       Impact factor: 7.561

6.  Association of Toll-Like Receptor 3 Single-Nucleotide Polymorphisms and Hepatitis C Virus Infection.

Authors:  Mashael R Al-Anazi; Sabine Matou-Nasri; Ayman A Abdo; Faisal M Sanai; Saad Alkahtani; Saud Alarifi; Abdullah A Alkahtane; Hamad Al-Yahya; Daoud Ali; Mohammed S Alessia; Bushra Alshahrani; Mohammed N Al-Ahdal; Ahmed A Al-Qahtani
Journal:  J Immunol Res       Date:  2017-01-03       Impact factor: 4.818

7.  Inhibition of intrahepatic gamma interferon production by hepatitis C virus nonstructural protein 5A in transgenic mice.

Authors:  Tatsuo Kanda; Robert Steele; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

8.  Increased baseline proinflammatory cytokine production in chronic hepatitis C patients with rapid virological response to peginterferon plus ribavirin.

Authors:  Gabriella Par; Laszlo Szereday; Timea Berki; Laszlo Palinkas; Melinda Halasz; Attila Miseta; Geza Hegedus; Julia Szekeres-Bartho; Aron Vincze; Bela Hunyady; Alajos Par
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

9.  Relative Expression of Toll-Like Receptors 2 and 7 mRNA in Peripheral Blood of Patients With Hepatitis C.

Authors:  Mahdi Dehghan-Manshadi; Hossein Hadinedoushan; Mohammad Kazem Amirbaigy; Fateme Zare; Gilda Eslami; Seyyed Ali Mirghanizade-Bafghi; Mohsen Akhondi-Meybodi
Journal:  Hepat Mon       Date:  2015-11-28       Impact factor: 0.660

10.  Peripheral blood toll-like receptor 4 correlates with rapid virological response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 1 patients.

Authors:  Chuan-Mo Lee; Tsung-Hui Hu; Sheng-Nan Lu; Jing-Houng Wang; Chao-Hung Hung; Chien-Hung Chen; Yi-Hao Yen
Journal:  BMC Gastroenterol       Date:  2016-07-25       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.